ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO519

A Report on Home Hemodialysis Training Time in Patients With Kidney Failure Using the Quanta SC+ Hemodialysis Device

Session Information

Category: Dialysis

  • 702 Dialysis: Home Dialysis and Peritoneal Dialysis


  • Bamforth, Ryan J., Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
  • Whitlock, Reid, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
  • Komenda, Paul, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
  • Gorbe, Kelley Lee, Quanta Dialysis Technologies Ltd, Alcester, Warwickshire, United Kingdom
  • Pietrafesa, Angela, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
  • Bebb, Charlotte, Nottingham University Hospitals NHS Trust, Nottingham, Nottingham, United Kingdom
  • Forbes, Suzanne, Barts Health NHS Trust, London, London, United Kingdom
  • Ahmed, Saeed, South Tyneside and Sunderland NHS Foundation Trust, South Shields, Tyne and Wear, United Kingdom
  • Collister, David Thomas, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada

Frequent self-care hemodialysis (HD) in the home setting has several advantages to patients and providers including improved health outcomes, health-related quality of life, patient satisfaction, and lower health care costs. The Quanta SC+ is a contemporary, portable HD device intended to be operated by a broad range of lay users. It was developed in collaboration with experienced home HD patients and human factors engineers with intuitive linear workflows, on-screen step-by-step instructions, and troubleshooting help screens that are easy to navigate. This study is a descriptive report on the home HD training time of first-time users of the Quanta SC+ HD device in the United Kingdom.


From August 2020 until March 2022, patients on dialysis across 5 sites in the United Kingdom were trained on the Quanta SC+ HD device as part of standard of care for self-care home HD as treatment for their kidney failure. We collected data on the number of total training weeks and sessions to be signed off as safe by a nephrologist and the frequency of training loss. Training time included organizational delays plus needling training time.


As of March 2022, a total of 34 patients completed training on the Quanta SC+ HD device. The mean age of the patients was 52.3 ± 15.1 years, 14 (41.2%) were female. Patients had an average dialysis vintage of 2.6 ± 2.2 years. A total of 9 (26.5%) patients were already on home HD and converted to Quanta SC+ from another device. Training time for these individuals before being signed off as safe by a nephrologist ranged from 2 to 3 weeks (6 to 9 sessions). A total of 25 (73.5%) patients converted to Quanta SC+ from another dialysis modality. The average training time for these individuals before being signed off as safe by a nephrologist was 6 weeks (18 sessions).


A descriptive report of 34 patients with kidney failure who trained for frequent self-care home HD with the Quanta SC+ HD device reported an average training time within expectations set from national kidney organizations with minimal training. These results indicate that the device is user-friendly and intuitive to learn.


  • Commercial Support